LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Formulation and optimization of long acting dual niosomes using Box-Behnken experimental design method for combinative delivery of Ethionamide and D-cycloserine in Tuberculosis treatment

Photo from wikipedia

Abstract The ability of niosomes to entrap both hydrophilic (D-Cycloserine) and lipophilic (Ethionamide) drugs was utilized to make an effective formulation for combating drug-resistant tuberculosis. The nanoformulation was statistically optimized… Click to show full abstract

Abstract The ability of niosomes to entrap both hydrophilic (D-Cycloserine) and lipophilic (Ethionamide) drugs was utilized to make an effective formulation for combating drug-resistant tuberculosis. The nanoformulation was statistically optimized using Box-Behnken experimental design and was found to be stable over a period of 6 months. The optimized formulation displayed acceptable % entrapment efficiencies (>70%) and optimum particle size (137.4 nm) along with sustained release up to 3 days. Mycobacterium Smegmatis was used as a model organism to assess bacterial inhibition. The dual drug loaded niosomes showed greater bacterial inhibition than the free drug combination. The blank nanocarrier failed to show any inhibition citing its biocompatible nature. The results overall suggest a potential combinatorial treatment strategy for tuberculosis treatment.

Keywords: using box; treatment; box behnken; tuberculosis; experimental design; behnken experimental

Journal Title: Colloids and Surfaces A: Physicochemical and Engineering Aspects
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.